The Immunohistochemistry Antibody Company

Home
Products
- All Antibodies
- IHC-plus Antibodies
Services
- Immunohistochemistry Studies
- Tissue Cross-Reactivity Screening
Distributors
Resources
- About our Tissue Bank
- Customer Support
- How to Buy
- IHC-plus Protocol
- LSBio Media
- Publications
- Antibody Reports
Company
- About LifeSpan
- Press Releases
- Holiday Schedule
- Contact Us

View Cart

General Cancer Screen 170 Tissue Microarray - LS-SCA170

This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.

Technical Help email

Request an IHC Study by email

PDF Spec Sheet - click here

Catalog ID:	LS-SCA170
Product Name:	General Cancer Screen 170
Description:	Bladder cancer with stage/grade and normal/non-neoplastic bladder
Format:	FFPE
Category:	Human Tumor and Normal
QA/QC:	H&E reviewed
Storage:	Short term RT; Long term 4ºC
Clinical History:	No
Tissue Marker:	No
Stage/Grade:	Yes
Core Diameter:	1.5 mm
Core Thickness:	5 µm
Cases:	40
Cores:	80
Slides Per Set:	1

LS-SCA170 Tissue Microarray Map

Slide Number 1

LABEL

	1	2	3	4	5	6	7	8	9	10
A	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
D	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
E	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
F	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
G	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
H	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla

Diagnosis Type Legend

Benign non-neoplastic

Diseased

Inflammatory

Malignant

Metastatic

Tumor

Unknown

Element Tissue Legend

Bladder (Bla); Bladder, Smooth muscle (Bla);

LS-SCA170 Element Details

Slide	Position	Species	Gender	Age	Tissue	Diagnosis	Diagnosis Type	TNM Tumor Classification	Tumor Grade
1	A1	Human	M	38 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T1N0M0	1
1	A2	Human	M	38 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T1N0M0	1
1	A3	Human	M	88 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T1N0M0	1
1	A4	Human	M	88 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T1N0M0	1
1	A5	Human	M	70 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2bN0M0	2
1	A6	Human	M	70 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2bN0M0	2
1	A7	Human	M	67 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	TxN0M0	1
1	A8	Human	M	67 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	TxN0M0	1
1	A9	Human	M	51 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2N0M0	1
1	A10	Human	M	51 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2N0M0	1
1	B1	Human	M	72 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2aN0M0	2
1	B2	Human	M	72 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2aN0M0	2
1	B3	Human	M	80 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T3N0M0	2
1	B4	Human	M	80 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T3N0M0	2
1	B5	Human	F	52 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T3N0M0	2
1	B6	Human	F	52 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T3N0M0	2
1	B7	Human	F	60 y	Bladder (Bla)	Transitional cell carcinoma	Malignant		2
1	B8	Human	F	60 y	Bladder (Bla)	Transitional cell carcinoma	Malignant		2
1	B9	Human	M	66 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T1N0M0	2
1	B10	Human	M	66 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T1N0M0	2
1	C1	Human	F	47 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	TxN0M0	2
1	C2	Human	F	47 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	TxN0M0	2
1	C3	Human	M	50 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2aN0M0	2
1	C4	Human	M	50 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2aN0M0	2
1	C5	Human	M	42 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2aMN0M0	2
1	C6	Human	M	42 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2aMN0M0	2
1	C7	Human	F	61 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T3N0M0	2
1	C8	Human	F	61 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T3N0M0	2
1	C9	Human	F	48 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T3N0M0	2
1	C10	Human	F	48 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T3N0M0	2
1	D1	Human	M	59 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T1N0M0	2
1	D2	Human	M	59 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T1N0M0	2
1	D3	Human	F	54 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T3NxM1	2
1	D4	Human	F	54 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T3NxM1	2
1	D5	Human	F	76 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T3N1M0	2
1	D6	Human	F	76 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T3N1M0	2
1	D7	Human	M	58 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	TxN0M0	2
1	D8	Human	M	58 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	TxN0M0	2
1	D9	Human	M	45 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T1N0M0	2
1	D10	Human	M	45 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T1N0M0	2
1	E1	Human	M	78 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2N0M0	2
1	E2	Human	M	78 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2N0M0	2
1	E3	Human	M	74 y	Bladder (Bla)	Transitional cell carcinoma with squamous metaplasia	Malignant	T2N0M0	3
1	E4	Human	M	74 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2N0M0	3
1	E5	Human	F	48 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2bN0M0	3
1	E6	Human	F	48 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2bN0M0	3
1	E7	Human	F	72 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2N0M0	3
1	E8	Human	F	72 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2N0M0	3
1	E9	Human	M	79 y	Bladder, Smooth muscle (Bla)	Transitional cell carcinoma	Malignant	T3N0M0
1	E10	Human	M	79 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T3N0M0	3
1	F1	Human	M	57 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2bN0M0	3
1	F2	Human	M	57 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2bN0M0	3
1	F3	Human	M	52 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2bN0M0	3
1	F4	Human	M	52 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2bN0M0	3
1	F5	Human	M	50 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2N0M0	3
1	F6	Human	M	50 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T2N0M0	3
1	F7	Human	M	77 y	Bladder (Bla)	Transitional cell carcinoma	Malignant		3
1	F8	Human	M	77 y	Bladder (Bla)	Transitional cell carcinoma	Malignant		3
1	F9	Human	F	42 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T3N0M0	3
1	F10	Human	F	42 y	Bladder (Bla)	Transitional cell carcinoma	Malignant	T3N0M0	3
1	G1	Human	F	48 y	Bladder (Bla)	Adjacent normal	Benign non-neoplastic
1	G2	Human	F	48 y	Bladder (Bla)	Adjacent normal	Benign non-neoplastic
1	G3	Human	M	72 y	Bladder, Smooth muscle (Bla)	Adjacent normal	Benign non-neoplastic
1	G4	Human	M	72 y	Bladder, Smooth muscle (Bla)	Adjacent normal	Benign non-neoplastic
1	G5	Human	M	55 y	Bladder (Bla)	Adjacent normal	Benign non-neoplastic
1	G6	Human	M	55 y	Bladder (Bla)	Adjacent normal	Benign non-neoplastic
1	G7	Human	M	67 y	Bladder (Bla)	Adjacent normal	Benign non-neoplastic
1	G8	Human	M	67 y	Bladder (Bla)	Adjacent normal	Benign non-neoplastic
1	G9	Human	M	50 y	Bladder (Bla)	Adjacent normal	Benign non-neoplastic
1	G10	Human	M	50 y	Bladder (Bla)	Adjacent normal	Benign non-neoplastic
1	H1	Human	F	21 y	Bladder (Bla)	Normal	Benign non-neoplastic
1	H2	Human	F	21 y	Bladder (Bla)	Normal	Benign non-neoplastic
1	H3	Human	F	21 y	Bladder (Bla)	Normal	Benign non-neoplastic
1	H4	Human	F	21 y	Bladder (Bla)	Normal	Benign non-neoplastic
1	H5	Human	F	15 y	Bladder (Bla)	Normal	Benign non-neoplastic
1	H6	Human	F	15 y	Bladder (Bla)	Normal	Benign non-neoplastic
1	H7	Human	F	18 y	Bladder (Bla)	Normal	Benign non-neoplastic
1	H8	Human	F	18 y	Bladder (Bla)	Normal	Benign non-neoplastic
1	H9	Human	M	30 y	Bladder (Bla)	Normal	Benign non-neoplastic
1	H10	Human	M	30 y	Bladder (Bla)	Normal	Benign non-neoplastic

PLEASE NOTE

For RESEARCH USE ONLY. Not intended for human diagnostic or therapeutic purposes.

Not for resale without prior written consent from LifeSpan BioSciences, Inc.